Status:
COMPLETED
Development of a Fetal Sex Assay From Maternal Whole Blood
Lead Sponsor:
Sequenom, Inc.
Conditions:
Fetal Sex Determination
Eligibility:
FEMALE
18-64 years
Brief Summary
Whole blood from pregnant women will be collected to develop a noninvasive fetal sex test.
Detailed Description
This is an observational study whereby samples will be tested to determine the presence or absence of fetal Y chromosome genes to test for the fetal sex of the baby. The blood draw will occur between ...
Eligibility Criteria
Inclusion
- Subject is 18-64 years of age
- Subject is female
- Subject is pregnant and between 6 and 16 weeks of gestation
- Subject provides a signed and dated informed consent
- If subject undergoes a routine ultrasound between weeks 16 and 28, she agrees to provide the fetal sex results
- If subject undergoes an invasive procedure, she agrees to provide the fetal sex results
Exclusion
- None
Key Trial Info
Start Date :
June 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2010
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT00970047
Start Date
June 1 2008
End Date
July 1 2010
Last Update
February 2 2011
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
NCOG Medical Group
San Diego, California, United States, 92037
2
IGO
San Diego, California, United States, 92121
3
Scripps Clinic Medial Group
San Diego, California, United States, 92128